ECZEMA THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Global Eczema Therapeutics Market – Regional Analysis

On the basis of region, the global eczema therapeutics market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America eczema treatment is expected to hold a dominant position during forecast period, owing to the availability of reimbursement for the treatment of eczema. For instance, in the U.S., Medicare covers the treatment for eczema. Under the policy, doctor visits, specialist appointments, and even other special treatments have coverage. Under the Medicare coverage, an eczema patient can pay nothing up to US$ 100 per month for the treatment for eczema, depending upon the seriousness of the disease.

Furthermore, Europe is also estimated to witness significant growth in the eczema therapeutics market, owing to the increasing research and development activities by the market players and research institute. For instance, on May 21, 2021, the researchers from Trinity College, Dublin, UK had conducted clinical trials for the treatment of atopic dermatitis. During their research, it was found that Upadacitinib drug was the most effective treatment for chronic, relapsing atopic dermatitis or eczema. The results for the clinical trials have been published in the Lancet Journal

Figure 2: Global Eczema Therapeutics Market (US$ Mn), by Region, 2021